Cryotherapy: A Safe Approach to Pulmonary Hemorrhage During VV-ECMO

J Investig Med High Impact Case Rep. 2022 Jan-Dec:10:23247096221074590. doi: 10.1177/23247096221074590.

Abstract

The number of hospitals with veno-venous extracorporeal membrane oxygenation (VV-ECMO) capabilities is expanding. To support an ECMO program, centers must be equipped to handle associated complications such as pulmonary hemorrhage. We describe a case series of 4 patients with life-threatening pulmonary bleeding and central airway obstruction. A therapeutic approach of anticoagulation cessation coupled with cryoextraction via flexible bronchoscopy led to successful restoration of airway patency without any adverse events. A low threshold to stop anticoagulation with a strong consideration of bronchoscopy with cryotherapy for pulmonary toilet should be done in patients with pulmonary hemorrhage during VV-ECMO.

Keywords: ARDS; acute respiratory distress syndrome; bronchoscopy; cryotherapy; extracorporeal life support; extracorporeal membrane oxygenation; hemoptysis; pulmonary hemorrhage.

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use
  • Cryotherapy / adverse effects
  • Extracorporeal Membrane Oxygenation*
  • Hemorrhage / etiology
  • Hemorrhage / therapy
  • Humans
  • Lung

Substances

  • Anticoagulants